Research Paper Volume 16, Issue 11 pp 9569—9583
Attenuating bone loss in osteoporosis: the potential of corylin (CL) as a therapeutic agent
Figure 7. Inhibition of OVX-induced bone loss by CL administration. (A) The 3D reconstruction image from bone samples. (B) The quantifying analysis of bone quality through BV/TV, Tb.Th, Tb.N, and Tb.Sp. The ns, not statistically significant; *P < 0.05; ***P < 0.001; ****P < 0.0001.